• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Zinc blend available

Article

OCuSOFT Inc.'s proprietary blend of zinc and phytase (Zytaze) is now available for physician dispensing. This proprietary medical food is designed to provide nutritional support to enhance the effectiveness of botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, or cosmetic procedures.

Richmond, TX-OCuSOFTInc.’s proprietary blend of zinc and phytase (Zytaze) is now available for physician dispensing.

This medical food is designed to provide nutritional support to enhance the effectiveness of botulinum toxin injections in the treatment of blepharospasm, hemifacial spasm, or cosmetic procedures.

The blend is one of organic zinc and phytase, an enzyme that aids zinc absorption and increases bioavailability. According to OCuSOFT, increasing zinc bioavailability is important because, to be effective, each botulinum toxin molecule must be associated with a zinc molecule, yet many patients’ diets are zinc-deficient.

Taking the zinc and phytase blend each day for 4 days before and on the day of an injection may increase both the effect of treatments and the duration of botulinum toxin, and could mean using less toxin, financial savings, increased safety, and more consistent botulinum toxin results for many patients, according to OCuSOFT.

Related Videos
Video 3 - "Approaching Asymptomatic Cases with Risk Factors"
Video 2 - "Do Dry Eye Diagnostics Change the Management of Dry Eye?"
Elias Kahan, MD, speaks at the 2024 ARVO meeting
Andrew Pucker, OD, PhD
Dr. SriniVas Sadda Discusses Vision for ARVO as New President: Collaboration, Funding Challenges, and Impact of Annual Meetings
© 2024 MJH Life Sciences

All rights reserved.